What is the main purpose of the Amended and Restated By-laws filed by Merck?

The primary purpose is to implement a "Majority Vote Resignation Policy" for directors, enhancing director accountability to shareholders by requiring resignation offers when a nominee fails to secure a majority of affirmative votes.

What triggers a director's resignation offer under the new policy?

A director nominee is required to offer their written resignation if they receive votes to withhold from the holders of at least a majority of the votes cast for the election of directors at a meeting where a quorum is present.

Who decides whether to accept a director's resignation?

After the director offers their resignation, the Nominating and Corporate Governance Committee will review it and make a recommendation to the Board of Directors. The Board of Directors will then make the final decision.

Will investors be informed about the Board's decision on a director's resignation?

Yes, the company commits to promptly disclosing the Board's decision and the explanation for it on a Form 8-K filing with the Securities and Exchange Commission.

MRK 8-K: Corporate Changes

Summary

This 8-K filing by Merck & Co., Inc. (MRK) on June 28, 2007, details amendments to its corporate bylaws, specifically concerning director resignations. The key change is the adoption of a "Majority Vote Resignation Policy" for directors. Under this new policy, any director nominee who receives a "withhold" vote from a majority of the cast votes in an election will be required to promptly offer their written resignation to the Nominating and Corporate Governance Committee. This policy aims to enhance director accountability to shareholders. The Nominating and Corporate Governance Committee will then review the resignation, considering factors such as the reasons for withheld votes and the director's qualifications. The Board of Directors will make a final decision on accepting the resignation, with any decision and its rationale to be publicly disclosed. This move reflects a growing trend towards greater shareholder influence in corporate governance.

Key Highlights

1Merck & Co., Inc. adopted Amended and Restated By-laws effective June 26, 2007.
2A new "Majority Vote Resignation Policy" for Directors has been implemented.
3Directors nominated who receive a majority of withheld votes must offer their resignation.
4The Nominating and Corporate Governance Committee will review the resignation offer.
5The Board of Directors will make the final decision on accepting the resignation.
6The company will disclose the Board's decision and reasoning via an 8-K filing.
7These bylaw amendments do not require shareholder approval.

Merck & Co., Inc. 8-K Report, Bylaw Amendment (Jun 28, 2007)

Summary

Key Highlights

Frequently Asked Questions